The Unitary Patent valid across EU one step closer

4.4.2013
On February 19, 2013, the EU ministries signed the agreement that will establish a single patent litigation system for Europe, the Unified Patent Court (UPC). The UPC will ensure a uniform applicability of patent law. The UPC is part of the Unitary Patent package that was approved in December 2012.

Following the signing of the agreement, the ratification process by national parliament can start. At least 13 of the 25 signatory countries are required to ratify the agreement, and those must include the UK, Germany and France.

The unitary patent system contributes to the internationalization of innovative growth companies. It will be a good option for companies that want to file a European patent designating many participating countries.

”Despite the promising and historical achievements so far, a lot of work lies ahead to ensure the unitary patent and UPC deliver on their promise. There are still many issues to be ironed out and open questions, such as costs. We do look forward to a successful ratification process and thus I would recommend companies to start already now evaluating the possible effects on their patent portfolios”, says Mikko Piironen, European Patent Attorney, Papula-Nevinpat.

News

Helsinki head office closed for Ascension Day 13 May 2021

Kindly note that our Helsinki head office will be closed for Ascension Day on Thursday 13 May 2021 and will be fully operational again on Friday 14 May 2021.

Folke Johansson, Markku Simmelvuo and Marina Smirnova named as WIPR Leaders 2021

Papula-Nevinpat’s Folke Johansson, Markku Simmelvuo and Marina Smirnova have again been named as IP Leaders in the 2021 edition of World Intellectual Property Review’s WIPR Leaders.

How Halton uses IPR to keep fresh air flowing indoors

Halton has been providing indoor air solutions since the 1960s. With Papula-Nevinpat’s help, the company has built an IP and trademark portfolio for some of the world’s most advanced indoor air technology.

Patenting pharmaceuticals in Russia – what to know

The last episode in our spring 2021 Russia-Eurasia IP webinar series covered pharmaceutical patenting in Russia. The article includes the main points you should know.